Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients, Neurol. Res, vol.34, pp.297-303, 2012. ,
Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS, Neuron, vol.67, pp.575-587, 2010. ,
UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis, Mol. Cell. Neurosci, vol.57, pp.104-114, 2013. ,
A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis, EMBO Mol. Med, vol.7, pp.526-572, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02106592
Neurodegeneration as a consequence of failed mitochondrial maintenance, Acta Neuropathol, 2011. ,
A case of severe hypermetabolism of non thyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study, J. Clin. Invest, vol.41, pp.1776-1804, 1962. ,
Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells, Biochim Biophys Acta, vol.1757, pp.21-30, 2006. ,
UCP2, a metabolic sensor coupling glucose oxidation to mitochondrial metabolism?, IUBMB Life, vol.61, pp.762-769, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02347239
, Scientific RepORtS |, vol.8, p.3953, 2018.
Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation, J. Biol. Chem, vol.276, pp.8705-8717, 2001. ,
A mitochondrial uncoupling artifact can be caused by expression of uncoupling protein 1 in yeast, Biochem. J, vol.356, pp.779-89, 2001. ,
Artifactual uncoupling by uncoupling protein 3 in yeast mitochondria at the concentrations found in mouse and rat skeletal-muscle mitochondria, Biochem. J, vol.361, pp.49-56, 2002. ,
No Evidence for a Basal, Retinoic, or Superoxide-induced Uncoupling Activity of the Uncoupling Protein 2 Present in Spleen or Lung Mitochondria, J. Biol. Chem, vol.277, pp.26268-26275, 2002. ,
Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism, Diabetes, vol.49, pp.143-56, 2000. ,
Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate?, FASEB J, vol.12, pp.715-739, 1998. ,
Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization, FASEB J, vol.22, pp.9-18, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02446962
UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation, Proc. Natl. Acad. Sci. USA, vol.111, pp.960-965, 2014. ,
Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis, J. Proteomics, vol.108, pp.55-64, 2014. ,
Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?, Diabetes, vol.50, pp.803-812, 2001. ,
ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells, Mol Carcinog, 2004. ,
New practical definitions for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay, Ann. Neurol, vol.78, pp.871-86, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01955612
Alteration of Fatty-Acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia, Am. J. Hum. Genet, vol.91, pp.1051-1064, 2012. ,
REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morphofunctional dysfunction, Hum. Mutat, vol.32, pp.1118-1127, 2011. ,
Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model, PLoS One, vol.9, p.103526, 2014. ,
Metabolic reprogramming during neuronal differentiation, Cell Death Differ, vol.23, pp.1502-1514, 2016. ,
Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation, Elife, vol.5, 2016. ,
Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming, Cell Stem Cell, vol.18, pp.396-409, 2016. ,
Emerging concepts in bioenergetics and cancer research: Metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy, Int. J. Biochem. Cell Biol, 2014. ,
The 'Omics' of Amyotrophic Lateral Sclerosis, Trends Mol. Med, vol.22, pp.53-67, 2016. ,
Mitochondrial bioenergetics and structural network organization, J Cell Sci, vol.120, pp.838-848, 2007. ,
Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology, J Biol Chem, vol.281, pp.37972-37979, 2006. ,
Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin, Brain Res. Bull, vol.89, pp.185-90, 2012. ,
Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice, Front. Cell. Neurosci, vol.8, p.353, 2014. ,
Defective cholesterol metabolism in amyotrophic lateral sclerosis, J. Lipid Res, vol.58, pp.267-278, 2017. ,
Pathophysiological and diagnostic implications of cortical dysfunction in ALS, Nat. Rev. Neurol, vol.12, pp.651-661, 2016. ,
Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis, J. Neurol. Sci, vol.156, pp.65-72, 1998. ,
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death, Ann. Neurol, vol.46, pp.787-90, 1999. ,
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice, J. Biol. Chem, vol.277, pp.29626-29659, 2002. ,
Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis, J. Neurochem, vol.83, pp.535-580, 2002. ,
The leaks and slips of bioenergetic membranes, FASEB J, vol.6, pp.2961-2966, 1992. ,
Decoupling of oxidative phosphorylation and photophosphorylation, Biochim. Biophys. Acta, vol.1018, p.1, 1990. ,
Urinary p75 ECD, Neurology, vol.88, pp.1137-1143, 2017. ,
Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy, J. Neurosci, vol.23, pp.5928-5963, 2003. ,
Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis, Neurobiol. Dis, vol.88, pp.148-60, 2016. ,
LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease, J. Proteome Res, vol.14, pp.467-78, 2015. ,
Mechanism for peroxisome proliferator-activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes, J. Biol. Chem, vol.277, pp.9562-9571, 2002. ,
Requirement of PPARalpha in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation, J. Lipid Res, vol.45, pp.2025-2062, 2004. ,
Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosis, Int. J. Clin. Exp. Med, vol.8, pp.3743-51, 2015. ,
The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability, Neurosci. Lett, 2016. ,
Mitochondrial Dysregulation Secondary to Endoplasmic Reticulum Stress in Autosomal Dominant Tubulointerstitial Kidney Disease -UMOD (ADTKD-UMOD), Sci. Rep, vol.7, p.42970, 2017. ,
Mutant TDP-43 Deregulates AMPK Activation by PP2A in ALS Models, PLoS One, vol.9, p.90449, 2014. ,
Preconditioning' with latrepirdine, an adenosine 5?-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1G93A mice, Neurobiol. Aging, vol.36, pp.1140-1150, 2015. ,
Reduced Activity of AMP-Activated Protein Kinase Protects against Genetic Models of Motor Neuron Disease, J. Neurosci, vol.32, pp.1123-1141, 2012. ,
, Scientific RepORtS |, vol.8, p.3953, 2018.
The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes, J. Neurochem, vol.73, pp.1674-82, 1999. ,
Adducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for DearLife, Front. Cell. Neurosci, vol.10, 2016. ,
Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects, Proc. Natl. Acad. Sci. USA, vol.95, pp.8892-8899, 1998. ,
A clinical trial of creatine in ALS, Neurology, vol.63, pp.1656-61, 2004. ,
Lactate involvement in neuron-glia metabolic interaction: (13)C-NMR spectroscopy contribution, Biochimie, vol.85, pp.841-849, 2003. ,
Adaptation Biology of the Mitochondrion to the Cellular Redox State in Physiology and Carcinogenesis, Antioxid. Redox Signal, vol.18, pp.808-849, 2013. ,
Physiological diversity of mitochondrial oxidative phosphorylation, Am J Physiol Cell Physiol, vol.291, pp.1172-82, 2006. ,
Rodent Models ofAmyotrophic Lateral Sclerosis, Curr. Protoc. Pharmacol, vol.69, pp.5-67, 2015. ,
, Neural Cell culture, A Practical Approach, 1995.
A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson's disease, Nat. Commun, vol.5, p.5181, 2014. ,
High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy, FASEB J, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02353771